September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
Research Shows Diabetes Patients Living Longer
Researchers in Scotland have shown that while diabetes is a growing problem for that country's population, patients diagnosed with the condition are living considerably longer than they would have in the past. This is particularly true for patients diagnosed with type 1 diabetes.
Diabetic Polyneuropathy: Is Pain a Component?
January 7th 2015Diabetic polyneuropathy (DPN) can exist with or without neuropathic pain. Roughly half of patients with types I and II diabetes mellitus (DM) develop DPN. In type 1 DM, patients start to notice symptoms of distal polyneuropathy after many years of chronic prolonged hyperglycemia. It's more aggressive in type 2 DM, and can develop after only a few years of known poor glycemic control and may be present at diagnosis.
Healthy Resolutions Show Benefits Long After New Year's Eve
With a new year comes New Year's resolutions, many of which involve getting healthy in the year ahead. A recent study has shown that by keeping those resolutions people can not only lose the weight they want but also avoid other health issues like diabetes.
Search for Diabetes Cure Highlights Top Stories of 2014
December 30th 2014Obesity and physical activity have become a focus of the healthcare community in the recent past and that was no exception in 2014. Over the past 12 months we have highlighted advancements in the treatment, diagnosis and impact of diabetes on our daily lives. Here is a look at the top 10 stories from the year.
Diagnosing and Treating Diabetes: The Difficulties of Subtype
December 23rd 2014As many as 15% of diabetics may be misdiagnosed with simple diabetes mellitus (DM) types 1 or 2. But DM presents as more than 50 unique types, and even among correctly diagnosed type 2 patients, 60 predisposing genetic variants exist.
FDA Approves New Weight-Management Drug
December 23rd 2014Saxenda (liraglutide [rDNA origin] injection) 3 mg has been approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese and overweight adults who have at least one weight-related comorbidity.
How Would You Initiate Insulin in this 53-Year-Old Man with T2DM?
December 16th 2014The decision to start insulin therapy requires frank dialogue with a patient about lifestyle, psychosocial, and employment matters. Given this patient's particulars, what type of insulin would you prescribe and on what schedule?
Charcot Foot: Diabetes at Risk
December 12th 2014Microvascular disease is a concern in patients with diabetes, and follows hyperglycemia-induced endothelial damage or endothelial dysfunction. Diabetic neuropathy is the most prominent microvascular consequence of diabetes, and often, the foot is involved.
Statins for Everyone: Maybe, Maybe Not
December 12th 2014The 2013 American College of Cardiology/American Heart Association guideline for management of low-density lipoprotein cholesterol to reduce atherosclerotic cardiovascular disease risk identified adults who could benefit from moderate- to high-intensity statin use.
Study Confirms Benefits of Exercise with Gastric Bypass Surgery
Gastric bypass surgery has been shown to improve quality of life for overweight and obese patients in a number of ways, including improving insulin sensitivity. Surgery combined with exercise has been shown to produce even greater benefits. A recent study evaluated the link between the two approaches and their effect on overall insulin sensitivity.